[ad_1] As the U.S. Supreme Court on Monday weighed the legality of Purdue Pharma’s bankruptcy…
Healthcare/Life Sciences
-
-
STOCK MARKET
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
by userby user[ad_1] Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion,…
-
[ad_1] Shares of Uber Technologies Inc. and Jabil Inc. rose in the extended session Friday…
-
STOCK MARKET
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
by userby user[ad_1] Pfizer Inc.’s stock tumbled 4% premarket Friday, after the company said it would not…
-
STOCK MARKET
Anti-smoking and male-enhancement drug maker charged with fraud after months on the lam
by userby user[ad_1] The late-night infomercials made lots of claims about the dissolvable oral strips being sold.…
-
STOCK MARKET
These advisers say markets are expecting unrealistic outcomes. Here are some alternatives.
by userby user[ad_1] Stocks are poised for an upbeat finish to the best month of gains for…
-
STOCK MARKET
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
by userby user[ad_1] Shares of Cabaletta Bio Inc. CABA, Gracell Biotechnologies Inc. GRCL and other smaller biotech…
-
STOCK MARKET
SpringWorks stock on track for record gain after FDA approves first treatment for rare type of aggressive tumors
by userby user[ad_1] SpringWorks Therapeutics Inc. shares SWTX were on track for a record percentage gain on…
-
STOCK MARKET
How to resolve your love-hate relationship with the holidays: 5 steps to saving money and your sanity
by userby user[ad_1] This article is reprinted by permission from . Americans love the winter holidays. In poll after poll we agree…
-
STOCK MARKET
Eli Lilly’s Mounjaro three times more effective than Ozempic for weight loss, real-world study finds
by userby user[ad_1] Eli Lilly’s Mounjaro is significantly more effective than Novo Nordisk’s Ozempic in producing weight…